Background: The first edition of the European position paper (EPP) on drug-induced sleep endoscopy (DISE) was published in 2014 with the aim to standardise the procedure, to provide an in-depth insight into the main aspects of this technique and to have a basis for future research. Since 2014, new studies have been published concerning new sedative agents or new insights into the pattern/levels of the obstruction depending on the depth of sedation. Therefore, an enlarged group of European experts in the field of sleep breathing disorders (SBD), including the most of the first DISE EPP main authors, has decided to publish an update of the European position paper on DISE, in order to include new evidence and to find a common language useful for reporting the findings of this endoscopic evaluation in adult population affected by SBD.
Methods:
The authors have evaluated all the available evidence reported in the literature and have compared experience among various departments in leading European centres in order to provide an update regarding the standardisation of the DISE procedure and an in-depth insight into the main aspects of this technique.
Results:
After the first European Position Consensus Meeting on DISE and its update, consensus was confirmed for indications, required preliminary examinations, where to perform DISE, technical equipment required, staffing, local anaesthesia, nasal decongestion, other medications, patient positioning, basics and special diagnostic manoeuvres, drugs and observation windows. So far, no consensus could be reached on a scoring and classification system. However, regarding this aim, the idea of an essential classification, such as VOTE with the possibility of its graded implementation of information and descriptions, seems to be the best way to reach a universal consensus on DISE classification at this stage. A common DISE language is mandatory, and attempts to come to a generally accepted system should be pursued.
| INTRODUCTION
The first edition of the European position paper on drug-induced sleep endoscopy (DISE) was published in 2014 with the aim to standardise the procedure, to provide an in-depth insight into the main aspects of this technique and to have a basis for future research. To achieve these endpoints, European specialists in ENT, anaesthesia and pulmonology among various departments in leading • Main sedative agents applied during drug-induced sleep endoscopy and its advantages and disadvantages.
• Scoring classification system for drug-induced sleep endoscopy and its standardization.
paper, considering its strictly related diagnostic and therapeutic characteristics.
| ETHICAL CONSIDERATIONS
The current position paper was designed and conducted in compliance with the principles of Good Clinical Practice regulations and the Helsinki Declaration.
| TERMINOLOGY
This procedure was first introduced as sleep nasendoscopy, abbreviated SNE. 2 Various other names that have been used are sleep endoscopy, 3, 4 video sleep nasendoscopy, 5 drug-induced sleep endoscopy 6,7 and fibre-optic sleep endoscopy. 8 In the first edition of this paper, we proposed the term DISE, to highlight the use of sedation during the study, but the authors have decided to adopt the term DISE, since the former could be considered a pleonasm and since the latter is more accepted and commonly used in the literature. If the procedure is performed during natural sleep, the work group suggests using the definition of natural sleep endoscopy (NSE).
| INDICATIONS
As DISE provides additional information about upper airway (UA) site(s) and pattern(s) of narrowing and obstruction in obstructive sleep apnoea (OSA) and snoring, it should be performed in selected patients in whom this additional information concerning the dynamics of the UA is considered to be of added value. Therefore, DISE can be performed when positive airway pressure (PAP) alternatives, such as upper airway surgery (UAS), oral appliance therapy (OAT) therapy, positional therapy (PT) or a combination of different treatment modalities, are considered. 9 Studies suggest that DISE in comparison with awake evaluations alters surgical treatment plans in approximately 50% of OSA patients. 10 Nevertheless, this gives no indication concerning the impact of DISE on surgical outcomes, which has been investigated in a few retrospective studies. It has been demonstrated that specific findings during DISE are associated with worse or better outcomes after certain procedures. Interpretation of PSG, UA examination and DISE findings combined direct surgical treatment plans and assist in predicting surgical outcomes.
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Besides being employed to evaluate treatment alternatives to CPAP, DISE can also be applied to improve understanding of the anatomical basis for surgical, MAD or PAP (positive airway pressure) In case DISE is being performed to evaluate OAT or CPAP failure, incomplete response or intolerance, the devices should be present.
| STAFFING
The following essential setting is required (Adult Sedation Guidelines, 
| LOCAL ANAESTHESIA, NASAL DECONGESTION , OTHER ME DICATION S
In the literature, nasal decongestion, nasal local anaesthesia and antisecretory drugs are described as preparatory measures and may be used as an option. [32] [33] [34] [35] [36] These preparatory measures can potentially interact with UA and breathing control and therefore have to be used with caution. UA suction would assist in obtaining a better UA assessment during DISE, if UA hypersalivation occurs. Performing DISE by means of an endoscope with a working channel could be useful in these patients, improving the UA assessment and the timing examination. We do not suggest an atropine infusion, because it could change the sleep physiology. Theoretically, the use of atropine-like drugs could be useful in patients who have excessive secretions that may interfere with the view attained. However, the working group felt that due to the lack of knowledge on the impact of these drugs on sleep physiology and the changes it may create on the cardiovascular system, this would be inappropriate.
Similarly, the working group agreed that although the use of local anaesthesia or decongestants may increase the ease of scope insertion and possibly reduce the incidence of nasal irritation, these drugs could interfere with the nasal resistance and therefore the airflow. 36 Thus, the dynamics of the upper airway would be made
somewhat different to what actually occurs during natural physiological sleep.
| PATIENT POSITIONING, BASIC AND SPECIAL DIAGNOSTIC MANOEUVRE
Ideally, the patient is positioned in a fashion mimicking sleeping habits at home, for example, 1 or two pillows, with or without dentures. The procedure is commonly performed in the supine position, even though patients may indicate to seldom sleep in the supine position.
In positional patients, in particular, performing DISE in both the lateral and supine position can be of added value, especially since the role of positional therapy is gaining momentum, 37 If treatment with OAT is considered, during DISE, it is recommended to mimic both the mandibular advancement and the vertical mouth opening in a standard and reproducible fashion, closely related to the OA characteristics, which might be constructed for the patient. 43, 44 There is evidence that a hyperprotrusion/maximal protrusion of the mandible has no predictive value towards the OAT outcome. 45 Therefore, performing a maximal mandibular protrusion manoeuvre is not advisable. If the patient's OAT is available during the DISE procedure, the working group recommends starting the sedation process with the OAT in situ and after the assessment of the UA with the OAT, to remove it and reassess in order to avoid arousals. This would inform the clinician on the efficacy of the OAT and would also allow determining if further advancement of the OAT is necessary or not. It should be taken into account that during DISE, an increase in vertical opening will increase the collapsibility of the UA at the level of the tongue base in a large majority of patients. Finally, if available, the working group recommends the use of a simulation bite in maximal comfortable protrusion (MCP) of the mandible during DISE in patients with OSA, which could be effective in predicting treatment response of OAT. 45 
| DRUGS
There is a great variability on the drug or combination of drugs used for DISE reported in the literature. Basically, midazolam and propofol are the two drugs most widely used. 46 Midazolam and propofol are used as single agents or together for sedation. Some authors also combine them with other drugs such as remifentanil or ketamine.
Another drug used for sedation is dexmedetomidine, an alpha 2 adrenergic drug that produces sedation plus analgesia by inhibiting the locus coeruleus. Dexmedetomidine is characterised by a slightly longer onset of action (5-10 minutes), and patients take longer time to wake, and some patients may not fall asleep at all. Nevertheless, explaining the mechanism of action of these drugs is beyond the scope of this article. The working group recommends reading the articles published Shteamer et al and by Ehsan et al for a deeper comprehension of the effects of these drugs on the brain and the UA. 46, 47 Most of the evidence that compares natural sleep and sedation is performed with propofol or midazolam as a single agent for sedation.
Therefore, these are the drugs that should be used for DISE, as they provide a state that mimics the critical closing pressure during natural sleep without significant differences in the AHI. [46] [47] [48] The addition of remifentanil to propofol increases the desaturation of the patient; therefore, it is not advisable despite its potential to reduce sneezing. 49 The dosage and management of propofol and midazolam are described in the following paragraph.
In Table 1 , the advantages and disadvantages of the use of propofol, midazolam and a combination of propofol and midazolam are described.
| Suggestions for drug dosage

| Propofol
The working group recommends the use of a syringe infusion pump with target-controlled infusion (TCI) technology as the standard mode for sedation if propofol is the drug chosen for sedation, as it provides sedation that is more stable and reliable than manual infusion schemes or bolus technique. 50, 51 If a TCI infusion pump is not available, then a syringe infusion pump for manually controlled infusion is better than bolus. Most of the patients achieve the adequate sedation level at an effective site concentration of 3.2 μg/mL.
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Therefore, a starting dose of 3 μg/mL could be applied, instead of the more conservative 2.0 or 2.5 μg/mL, in order to achieve a quicker sedation. However, the physician must always consider that if the sedation is achieved too quickly, a more consistent number of central apnoeas can occur at the beginning, creating a false image of obstruction. We describe the 3 possibilities for performing DISE by propofol (Table 2) 
b. Manually controlled infusion
Delivering dose: 50-100 mL/h depending on the patient response. 
| Combination of Propofol + Midazolam (variations are possible according to team experience)
When these two drugs are combined, the sedation is quicker. Nevertheless, the patient sneezes more frequently than with propofol alone, making the exploration more difficult. 52 Midazolam is used in first place using a single bolus starting dose of 0.05 mg/kg. After 2 minutes, the sedation proceeds with propofol performed by TCI (effective site concentration), with a starting dose of 1.5-3.0 μg/mL. If required, increasing rate 0.2-0.5 μg/mL every 2 minutes is suggested until a stable sedation is achieved ( Table 2 ).
| OBSERVATION WINDOW
The working group suggests observing during a stable sedation level and consistent breathing pattern. This ideal observation window would typically last at least two cycles or one minute but it may take longer both for each segment of UA and during the manoeu- Therefore, the BIS range values of 80-60 are suggested just as a general rule and it might not be optimal for every SBD patient. However, further research is needed on the validation of using EEGderived indices during DISE, as well as with polygraphic real-time monitoring.
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| LIST AND DEFINITIONS OF TH E TARGET EVENTS
| Snoring
Pharyngeal and/or laryngeal vibration, without obstruction.
| Apnoea/hypopnoea
Pharyngeal and/or laryngeal complete or partial obstruction.
| Collapse patterns
anteroposterior or circumferential soft palate collapse, pharyngeal lateral wall collapse, tongue base collapse, epiglottic trapdoor phenomenon, secondary epiglottic collapse, involvement of ary-epiglottic folds ( Figures 1, 2A -B, 3A-B, 4A-B, 5A-B, 6A-B).
| SCORING AND CLASSIFICATION
SYSTEMS
Several DISE scoring and classification systems are reported in the literature (Table 3) . 35, 40, [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] The existence of so many classifications is a representation of the complex anatomy of the UA. We would like to make some comments on the anatomical areas. Soft palate, uvula and the corre- 
| Levels vs structures
There was agreement on the fact that assessment of the nose and nasopharynx does not have the highest priority during DISE in adult population. In the first place, the role of the nose and nasopharynx is not as important as previously thought. Secondly, the situation in the nose and nasopharynx does not differ during awake and sleep stages. Regarding the number of levels, some presently used systems identify four levels of obstruction, others distinguish five. Some systems use levels, others prefer structures, and others, for pragmatic reasons, use a hybrid system, including both levels and structures.
Unfortunately, consensus on four or five levels/structures and on levels vs structures has not been obtained. Some see oropharyngeal wall and tonsil as one level, and others try to distinguish between oropharynx and tonsils.
| Severity
Some systems have only 3 degrees of severity (none, partial and complete obstruction), whereas other systems use a semiquantitative system with 0%-25%, 25%-50%, 50%-75% and 75%-100% of 
| OTHER TECHNIQUE S FOR UA ASSESSMENT
Upper airway evaluation is considered to be vital in order to attain site-specific treatment and thus better surgical and nonsurgical treatment outcomes. 77 
| RECOMMEND ED REPORT FORMAT
After any DISE procedure, the patient should have a report explaining the procedure and the findings of the UA assessment. In that report, we recommend to clearly report the drug/drugs used for the sedation, as well as the dosage achieved, and whether there were some other drugs different from the sedative one used (as decongestant, antisecretory drugs or others). It is also mandatory to report the sedation level reached as assessed by EEG-derived signal (BIS, CSI or others) if used, and, finally, the modification of the UA obstruction pattern, in lateral and supine position, following head rotation and/or mandibular manoeuvres has been performed. In order to compare UA DISE assessment between the patients and the different operators, it is of upmost importance to adopt and report a DISE classification score system (Appendix 1).
| FUTURE RESEARCH AGEND A
Some areas for future research can be defined:
• To come to one universally accepted scoring and classification system for DISE. Consensus should be reached on levels vs structures and number (four of five) of levels/structures, severity (none/partial/complete vs semiquantitative assessment) and configuration of obstruction, in order to make this effort easier an essential agreement on VOTE as basic classification has been reached.
• To compare results and predictive power in non-PAP therapies of DISE with the use of standard VOTE classification.
• To implement and modify VOTE classification with new suggestions after its use in the next years.
• To promote a worldwide open dataset on DISE videos in order to compare different endoscopic patterns and findings, evaluated by means of a universally accepted DISE classification system.
• To assess in more detail whether certain DISE findings are related to treatment outcome and treatment advice.
• To assess the role of DISE for titration of titratable OSA therapies such as upper airway stimulation therapy or OA therapy.
• To better understand the impact of the use of the sedative drugs and their influence on UA collapse levels and patterns, as well as their influence on sleep patterns and stages.
• To improve the options for the measurement of the depth of sedation during DISE; different EEG-derived indices available should be evaluated and compared.
• To further compare the differences in degree, level and pattern of UA collapse observed during DISE vs during natural sleep and awake endoscopy.
• To further explore the potential of DISE for the optimisation of OSA treatment, providing new insight into nonanatomical SDB DE VITO ET AL.
| 1549 pathophysiological factors and its relationship with UA configuration during DISE.
• To devise a thorough method of calculating the cost-effectiveness of DISE in clinical practice.
• To assess and study the characteristics of central apnoea during DISE taking into account that oesophageal pressure measurement is regarded as the gold standard measurement of respiratory effort.
• To standardise the methods for application of a reproducible mandibular advancement during DISE in order to mimic OA wear in an appropriate fashion.
• To increase the reproducibility of the mouth closing during DISE taking into account the importance of vertical opening in relation to UA resistance.
• To improve the knowledge of sedative agents effects on UA and central nervous system, for achieving a better protocol of sedation.
| CONCLUSION
After the first European Position Consensus Meeting on DISE and its update, consensus was reached on indications, required preliminary examinations, where to perform DISE, technical equipment required, staffing, local anaesthesia, nasal decongestion, other medications, patient positioning, basics and special diagnostic manoeuvres, drugs and observation windows. So far, no consensus could be reached on a scoring and classification system. However, regarding this aim, the idea of an essential classification, such as VOTE with the possibility of its graded implementation of information and descriptions, seems to be the best way to reach a universal consensus on DISE classification at this stage. A common DISE language is mandatory and attempts to come to a generally accepted system should be pursued.
